News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32,701 Results
Type
Article (1535)
Company Profile (4)
Press Release (31162)
Section
Business (14597)
Career Advice (84)
Deals (1792)
Drug Development (3180)
Employer Resources (1)
FDA (569)
Job Trends (638)
News (19278)
Policy (859)
Tag
Academia (43)
Accelerated approval (2)
Allergies (8)
Alliances (1093)
ALS (6)
Alzheimer's disease (33)
Antibody-drug conjugate (ADC) (18)
Approvals (599)
Artificial intelligence (16)
Autoimmune disease (6)
Automation (1)
Bankruptcy (7)
Best Places to Work (553)
Biosimilars (5)
Biotechnology (2)
Bladder cancer (27)
Brain cancer (4)
Breast cancer (64)
Cancer (235)
Cardiovascular disease (19)
Career advice (82)
CAR-T (6)
Cell therapy (17)
Cervical cancer (1)
Clinical research (2876)
Collaboration (35)
Company closure (1)
Compensation (21)
Complete response letters (1)
COVID-19 (60)
CRISPR (2)
C-suite (11)
Cystic fibrosis (20)
Data (350)
Depression (6)
Diabetes (23)
Diagnostics (278)
Digital health (3)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (4)
Earnings (13851)
Employer resources (1)
Events (2293)
Executive appointments (8)
FDA (822)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (21)
Gene editing (2)
Generative AI (1)
Gene therapy (18)
GLP-1 (37)
Government (77)
Guidances (142)
Healthcare (745)
HIV (1)
IgA nephropathy (13)
Immunology and inflammation (8)
Immuno-oncology (1)
Indications (6)
Infectious disease (69)
Inflammatory bowel disease (10)
Intellectual property (9)
Interviews (13)
IPO (1355)
IRA (1)
Job creations (120)
Job search strategy (69)
Kidney cancer (2)
Layoffs (10)
Legal (113)
Liver cancer (1)
Lung cancer (23)
Lymphoma (10)
Management (1)
Manufacturing (7)
MASH (9)
Medical device (702)
Medtech (706)
Mergers & acquisitions (467)
Metabolic disorders (55)
Multiple sclerosis (19)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (7)
Neuroscience (89)
NextGen: Class of 2026 (140)
Non-profit (57)
Obesity (21)
Opinion (4)
Ovarian cancer (5)
Pain (4)
Pancreatic cancer (6)
Parkinson's disease (6)
Patents (16)
Patient recruitment (8)
Peanut (1)
People (876)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (685)
Phase 2 (1131)
Phase 3 (1123)
Pipeline (685)
Policy (1)
Postmarket research (191)
Preclinical (396)
Press Release (1)
Prostate cancer (13)
Radiopharmaceuticals (9)
Rare diseases (48)
Real estate (155)
Recruiting (1)
Regulatory (817)
Reports (6)
Research institute (43)
Resumes & cover letters (2)
Rett syndrome (1)
RSV (6)
Schizophrenia (5)
Series A (1)
Series B (1)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (5)
Sponsored (2)
Startups (59)
Stomach cancer (1)
Supply chain (1)
The Weekly (1)
Vaccines (12)
Venture capital (2)
Weight loss (18)
Women's health (7)
Date
Last 7 days (20)
Last 30 days (68)
Last 365 days (1871)
2026 (81)
2025 (1896)
2024 (1940)
2023 (2174)
2022 (3185)
2021 (3778)
2020 (2912)
2019 (1382)
2018 (1071)
2017 (867)
2016 (569)
2015 (779)
2014 (527)
2013 (313)
2012 (403)
2011 (494)
2010 (459)
Location
Africa (24)
Alabama (1)
Arizona (10)
Arkansas (1)
Asia (1707)
Australia (244)
California (618)
Canada (141)
China (47)
Colorado (32)
Connecticut (40)
Delaware (35)
Europe (3947)
Florida (80)
Georgia (23)
Idaho (1)
Illinois (43)
India (4)
Indiana (51)
Iowa (1)
Japan (34)
Kansas (1)
Kentucky (2)
Louisiana (8)
Maine (12)
Maryland (75)
Massachusetts (440)
Michigan (32)
Minnesota (30)
Missouri (8)
Montana (1)
Nevada (2)
New Hampshire (7)
New Jersey (289)
New York (137)
North Carolina (58)
Northern California (306)
Ohio (20)
Pennsylvania (164)
South America (36)
South Carolina (1)
Southern California (266)
Tennessee (5)
Texas (78)
United States (2353)
Utah (28)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (3)
Wyoming (1)
32,701 Results for "109".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
December 17, 2025
·
7 min read
Press Releases
Aera Therapeutics to Present Preclinical Data on AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases, at the 67th American Society of Hematology (ASH) Annual Meeting
December 3, 2025
·
2 min read
Press Releases
Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
October 20, 2025
·
9 min read
Press Releases
Apnimed to Highlight AD109 and the Burden of Obstructive Sleep Apnea (OSA) at World Sleep Congress 2025
September 4, 2025
·
5 min read
Press Releases
Immuno-Oncology Drugs Market Attains at USD 109.39 Billion in 2025
July 23, 2025
·
1 min read
Press Releases
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
October 22, 2025
·
5 min read
Press Releases
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
October 23, 2025
·
12 min read
Press Releases
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
September 22, 2025
·
3 min read
Press Releases
Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases
September 25, 2025
·
2 min read
Press Releases
Apnimed Announces Acceptance of Two Late-breaking Presentations and a Core Interactive Session at the CHEST Annual Meeting Highlighting New Positive AD109 Phase 3 Data and the Current Unmet Need in Obstructive Sleep Apnea
October 8, 2025
·
6 min read
1 of 3,271
Next
